Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 2Spinal Fractures 1Spinal Diseases 1Solid Tumors 1Multiple Myeloma 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Vertebroplasty × Clear all
NCT00819832 2023-03-24

Anderson Circulating Tumor Cell Burden (CTCB) Study

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 2 charts

Neoplasms, Spinal Diseases

NCT02376933 2018-11-07

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

University of Arizona

Phase NA Terminated
11 enrolled 6 charts
Plasma cell

Multiple Myeloma, Neoplasms, Spinal Fractures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡